Binh Dinh Pharmaceutical and Medical Equipment JSC (HOSE:DBD)
Vietnam flag Vietnam · Delayed Price · Currency is VND
52,700
-100 (-0.19%)
At close: Feb 9, 2026

HOSE:DBD Income Statement

Millions VND. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
1,865,2321,727,5481,651,7701,554,8211,558,504
Revenue Growth (YoY)
7.97%4.59%6.24%-0.24%23.99%
Cost of Revenue
983,372894,975853,250787,170935,939
Gross Profit
881,861832,573798,520767,652622,566
Selling, General & Admin
557,161526,981501,538494,312405,437
Operating Expenses
557,161526,981501,538494,312405,437
Operating Income
324,700305,592296,982273,339217,129
Interest Expense
-3,847-4,058-6,998-1,916-1,325
Interest & Investment Income
20,03611,60511,6358,7335,137
Earnings From Equity Investments
12,28027,06328,70424,78616,083
Currency Exchange Gain (Loss)
2,644-947.49-482.96354.16733.11
Other Non Operating Income (Expenses)
-11,308-12,119-9,753-6,739-5,310
EBT Excluding Unusual Items
344,506327,136320,086298,558232,448
Gain (Loss) on Sale of Investments
--2,000---
Pretax Income
344,506325,136320,086298,558232,448
Income Tax Expense
53,75849,95451,03155,00343,324
Net Income
290,748275,182269,055243,555189,124
Preferred Dividends & Other Adjustments
-38,52537,66834,09826,477
Net Income to Common
290,748236,656231,387209,457162,646
Net Income Growth
5.66%2.28%10.47%28.78%19.80%
Shares Outstanding (Basic)
9494949494
Shares Outstanding (Diluted)
9494949494
Shares Change (YoY)
1.00%--0.00%--0.07%
EPS (Basic)
3077.052529.632473.312238.881738.52
EPS (Diluted)
3077.052529.632473.002238.881738.52
EPS Growth
21.64%2.29%10.46%28.78%17.16%
Free Cash Flow
216,289115,985148,66382,18462,932
Free Cash Flow Per Share
2289.031239.771589.06878.47672.68
Dividend Per Share
-2000.000-1600.000-
Gross Margin
47.28%48.19%48.34%49.37%39.95%
Operating Margin
17.41%17.69%17.98%17.58%13.93%
Profit Margin
15.59%13.70%14.01%13.47%10.44%
Free Cash Flow Margin
11.60%6.71%9.00%5.29%4.04%
EBITDA
374,264352,272342,951315,005255,818
EBITDA Margin
20.06%20.39%20.76%20.26%16.41%
D&A For EBITDA
49,56546,67945,97041,66538,689
EBIT
324,700305,592296,982273,339217,129
EBIT Margin
17.41%17.69%17.98%17.58%13.93%
Effective Tax Rate
15.60%15.36%15.94%18.42%18.64%
Revenue as Reported
1,865,2321,727,5481,651,7701,554,8211,558,504
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.